Navigation Links
News from the Latest Issue of Molecular Medicine

New research from the bimonthly biomedical journal, Molecular Medicine. Molecular Medicine publishes research concerned with the pathogenesis of disease at the molecular level, in order to design specific molecular tools for disease diagnosis, treatment and prevention.

(Vocus) January 12, 2010 -- By the time a person experiences symptoms of an aggressive brain tumor it is often too late. Dr. Christina Piperi and her colleagues at the University of Athens Medical School have discovered genetic fingerprints of the glioblastoma multiforme brain tumor cell that could ultimately be used to diagnosis the tumor earlier in the disease process. They found that analyzing the methylation status helps differentiate normal and disease cells. Looking at four genes activated in glioma, they found that two of them – MGMT and RAR – were significantly more methylated in 58.8% to 70.58% of analyzed glioblastoma multiforme cases. This study also highlights a potential link between methylation patterns and a potent cytokine, IL-6, suggesting a specific role for inflammation mediators in the regulation of gene methylation. The hope is that the finding could offer clues to the aggressive nature of the tumor and point to new treatment avenues.

In another study, Stephanie L. Nott, Mesut Miyan and colleagues at the University of Rochester in upstate New York have discovered a potential treatment for endocrine resistant breast cancer tumors. It is well known that the estrogen hormone 17²-estradiol (E2), is involved in the initiation and progression of some types of breast cancer. Estrogen receptors have been used as transcription factors to mediate the effects of E2. That has been the basis for the state-of-the-art treatments for ER-positive breast cancer. But they do not work for ER-negative breast tumors. Dr. Nott and her colleagues tested the idea that they could design a transcription factor that regulates the estrogen responsive elements (EREs) of genes to stop the spread of ER-negative tumors. They used adenovirus infected ER-negative tumor cells derived from a breast adenocarcinoma. The monotransregulator repressed cell proliferation and infiltration and induced cell death by turning on genes required for the estrogen responsive elements to interact. “Specific regulation of genes bearing EREs could offer a therapeutic approach for de novo endocrine-resistant breast cancers,” the scientists said.

Enclosed is a table of contents for the latest issue. You can view all of the articles in the September-October issue by visiting the journal’s Web site at

Molecular Medicine is published by The Feinstein Institute for Molecular Research. The peer-reviewed journal strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. The journal, a bimonthly publication, serves as a forum through which scientists and researchers can communicate recent discoveries to a multi-disciplinary, international audience interested in understanding and curing disease.

To listen to the latest podcast on these studies visit


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Fewer headaches on the horizon thanks to latest guidelines
2. URACs Latest Podcast Highlights Pro-Change Behavior Systems Lifestyle Management Program
3. Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industrys Controlling Hand in Health Reform Debate, According to Consumer Watchdog
4. GemaTech Launches Portable Recovery Unit. The Latest Design in Emergency Telecoms Resilience and Continuity
5. Latest epidemic? High cholesterol, obesity in fruit flies
6. Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at Londons Online Information 2009 Conference
7. H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News
8. ASAP Systems Releases Latest Version of their Passport Inventory and Asset Tracking Software with New Security Features and Administrative Tools
9. Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms
10. Leaders in the Study of Allosteric Modulation to Discuss Latest Research at Allosteric and Orthosteric Modulator Congress
11. Premier Plastic Surgery of Kansas Citys Extended Website Provides Latest Information on Male and Female Cosmetic Surgery
Post Your Comments:
Related Image:
News from the Latest Issue of Molecular Medicine
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology: